Nancy Whiting
Direttore/Membro del Consiglio presso CARIBOU BIOSCIENCES, INC.
Patrimonio netto: - $ in data 31/05/2024
Profilo
Dr. Nancy C.
Whiting is an Independent Director at Boundless Bio, Inc., a Chief Executive Officer & Director at Recludix Pharma, Inc. and an Independent Director at Caribou Biosciences, Inc. She is on the Board of Directors at Boundless Bio, Inc., Recludix Pharma, Inc. and Caribou Biosciences, Inc. Dr. Whiting was previously employed as a President, Secretary & Director by Cascadian Therapeutics LLC and an Executive VP-Strategy, Alliances & Communications by Seagen Inc. She received her undergraduate degree from the University of British Columbia and a graduate degree from the University of Washington.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 15/04/2024 | 0 ( -.--% ) | - $ | 31/05/2024 | |
BOUNDLESS BIO INC.
-.--% | 28/03/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Nancy Whiting
| Società | Posizione | Inizio |
|---|---|---|
| CARIBOU BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 24/08/2021 |
| BOUNDLESS BIO, INC. | Direttore/Membro del Consiglio | 02/10/2023 |
Recludix Pharma, Inc.
 Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Recludix Pharma, Inc. is a biotechnology company that develops platform approaches to discover potent and selective inhibitors of challenging protein targets. The company is based in San Diego, CA. The company was founded by Brian Hodous, Nicholas B. Lydon, Patrick P. Zarrinkar, Daniel K. Treiber. Nancy C. Whiting has been the CEO of the company since 2021. | Amministratore Delegato | 01/09/2021 |
Precedenti posizioni note di Nancy Whiting
| Società | Posizione | Fine |
|---|---|---|
| CASCADIAN THERAPEUTICS INC (USA) | Presidente | - |
| SEAGEN INC. | Public Communications Contact | - |
Formazione di Nancy Whiting
| University of Washington | Graduate Degree |
| University of British Columbia | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CARIBOU BIOSCIENCES, INC. | Health Technology |
| BOUNDLESS BIO, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Seagen Inc.
 Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Cascadian Therapeutics LLC was a clinical-stage biopharmaceutical company, which focused on the development of therapeutic products for the treatment of cancer. Its product ONT-380, was an orally active and selective small-molecule HER2 inhibitor. The firm also developed preclinical product candidates in oncology using Chk1 kinase inhibitor and protocell technology. The company was founded on August 23, 1985 and was headquartered in Bothell, WA. | Health Technology |
Recludix Pharma, Inc.
Recludix Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Recludix Pharma, Inc. is a biotechnology company that develops platform approaches to discover potent and selective inhibitors of challenging protein targets. The company is based in San Diego, CA. The company was founded by Brian Hodous, Nicholas B. Lydon, Patrick P. Zarrinkar, Daniel K. Treiber. Nancy C. Whiting has been the CEO of the company since 2021. | Commercial Services |
- Borsa valori
- Insiders
- Nancy Whiting
